Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Griffin

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Globalization and Health|January 15, 2020
Methods to promote equity in health resource allocation in low- and middle-income countries: an overviewJames Love-Koh, Susan Griffin, Edward Kataika, et al.
Pharmacoeconomics|January 19, 2013
When does NICE recommend the use of health technologies within a programme of evidence development? : a systematic review of NICE guidanceLouise Longworth, Jihee Youn, Laura Bojke, et al.
BMC Medicine|February 15, 2019
High-throughput, non-invasive prenatal testing for fetal rhesus D status in RhD-negative women: a systematic review and meta-analysisHuiqin Yang, Alexis Llewellyn, Ruth Walker, et al.
Pharmacoeconomics|June 10, 2016
Daclatasvir for the Treatment of Chronic Hepatitis C: A Critique of the Clinical and Economic EvidenceAlexis Llewellyn, Rita Faria, Beth Woods, et al.
Neurochemistry International|June 16, 2011
Presynaptic malfunction: the neurotoxic effects of cadmium and lead on the proton gradient of synaptic vesicles and glutamate transportTatiana Borisova, Natalia Krisanova, Roman Sivko, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 13, 2025
Population Health and Health Inequality Impacts of the National Abdominal Aortic Aneurysm Screening Programme (NAAASP) in EnglandShainur Premji, Simon M Walker, James Koh, et al.
Pharmacoeconomics|September 7, 2012
Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisalJane Burch, Susan Griffin, Claire McKenna, et al.
Clinical & Experimental Ophthalmology|November 14, 2017
Gaming to improve vision: 21st century self-monitoring for patients with age-related macular degenerationHessom Razavi, Elizabeth Baglin, Pyrawy Sharangan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
Unifying Research and Reimbursement Decisions: Case Studies Demonstrating the Sequence of Assessment and Judgments RequiredClaire McKenna, Marta Soares, Karl Claxton, et al.
Pharmacoeconomics|March 20, 2019
The Clinical and Cost Effectiveness of Inotuzumab Ozogamicin for the Treatment of Adult Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia: An Evidence Review Group Evaluation of a NICE Single Technology AppraisalEdward Cox, Ros Wade, Mathilde Peron, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Globalization and Health|January 15, 2020
Methods to promote equity in health resource allocation in low- and middle-income countries: an overviewJames Love-Koh, Susan Griffin, Edward Kataika, et al.
Pharmacoeconomics|January 19, 2013
When does NICE recommend the use of health technologies within a programme of evidence development? : a systematic review of NICE guidanceLouise Longworth, Jihee Youn, Laura Bojke, et al.
BMC Medicine|February 15, 2019
High-throughput, non-invasive prenatal testing for fetal rhesus D status in RhD-negative women: a systematic review and meta-analysisHuiqin Yang, Alexis Llewellyn, Ruth Walker, et al.
Pharmacoeconomics|June 10, 2016
Daclatasvir for the Treatment of Chronic Hepatitis C: A Critique of the Clinical and Economic EvidenceAlexis Llewellyn, Rita Faria, Beth Woods, et al.
Neurochemistry International|June 16, 2011
Presynaptic malfunction: the neurotoxic effects of cadmium and lead on the proton gradient of synaptic vesicles and glutamate transportTatiana Borisova, Natalia Krisanova, Roman Sivko, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 13, 2025
Population Health and Health Inequality Impacts of the National Abdominal Aortic Aneurysm Screening Programme (NAAASP) in EnglandShainur Premji, Simon M Walker, James Koh, et al.
Pharmacoeconomics|September 7, 2012
Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisalJane Burch, Susan Griffin, Claire McKenna, et al.
Clinical & Experimental Ophthalmology|November 14, 2017
Gaming to improve vision: 21st century self-monitoring for patients with age-related macular degenerationHessom Razavi, Elizabeth Baglin, Pyrawy Sharangan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
Unifying Research and Reimbursement Decisions: Case Studies Demonstrating the Sequence of Assessment and Judgments RequiredClaire McKenna, Marta Soares, Karl Claxton, et al.
Pharmacoeconomics|March 20, 2019
The Clinical and Cost Effectiveness of Inotuzumab Ozogamicin for the Treatment of Adult Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia: An Evidence Review Group Evaluation of a NICE Single Technology AppraisalEdward Cox, Ros Wade, Mathilde Peron, et al.
Pageof 10